G Medical Innovations Holdings Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.0621
- Today's High:
- $0.0835
- Open Price:
- $0.0621
- 52W Low:
- $0.05
- 52W High:
- $11.8965
- Prev. Close:
- $0.0613
- Volume:
- 80138
Company Statistics
- Market Cap.:
- $1.78 million
- Book Value:
- -4.815
- Revenue TTM:
- $4.42 million
- Operating Margin TTM:
- -620.14%
- Gross Profit TTM:
- $1.50 million
- Profit Margin:
- 0%
- Return on Assets TTM:
- -223.33%
- Return on Equity TTM:
- -865.21%
Company Profile
G Medical Innovations Holdings Ltd had its IPO on 2018-01-31 under the ticker symbol GMVD.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. G Medical Innovations Holdings Ltd has a staff strength of 84 employees.
Stock update
Shares of G Medical Innovations Holdings Ltd opened at $0.06 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.06 - $0.08, and closed at $0.07.
This is a +6.69% increase from the previous day's closing price.
A total volume of 80,138 shares were traded at the close of the day’s session.
In the last one week, shares of G Medical Innovations Holdings Ltd have slipped by -0.91%.
G Medical Innovations Holdings Ltd's Key Ratios
G Medical Innovations Holdings Ltd has a market cap of $1.78 million, indicating a price to book ratio of 6.0906 and a price to sales ratio of 0.4842.
In the last 12-months G Medical Innovations Holdings Ltd’s revenue was $4.42 million with a gross profit of $1.50 million and an EBITDA of $-26652000. The EBITDA ratio measures G Medical Innovations Holdings Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, G Medical Innovations Holdings Ltd’s operating margin was -620.14% while its return on assets stood at -223.33% with a return of equity of -865.21%.
In Q2, G Medical Innovations Holdings Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 7.9%.
G Medical Innovations Holdings Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-18.76 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into G Medical Innovations Holdings Ltd’s profitability.
G Medical Innovations Holdings Ltd stock is trading at a EV to sales ratio of 0.55 and a EV to EBITDA ratio of -0.1694. Its price to sales ratio in the trailing 12-months stood at 0.4842.
G Medical Innovations Holdings Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $4.83 million
- Total Liabilities
- $9.11 million
- Operating Cash Flow
- $-900000.00
- Capital Expenditure
- $895500
- Dividend Payout Ratio
- 0%
G Medical Innovations Holdings Ltd ended 2024 with $4.83 million in total assets and $0 in total liabilities. Its intangible assets were valued at $4.83 million while shareholder equity stood at $-7353000.00.
G Medical Innovations Holdings Ltd ended 2024 with $0 in deferred long-term liabilities, $9.11 million in other current liabilities, 4835000.00 in common stock, $-115263000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $295000.00 and cash and short-term investments were $295000.00. The company’s total short-term debt was $1,809,000 while long-term debt stood at $0.
G Medical Innovations Holdings Ltd’s total current assets stands at $1.99 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $944000.00 compared to accounts payable of $4.66 million and inventory worth $292000.00.
In 2024, G Medical Innovations Holdings Ltd's operating cash flow was $-900000.00 while its capital expenditure stood at $895500.
Comparatively, G Medical Innovations Holdings Ltd paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.07
- 52-Week High
- $11.8965
- 52-Week Low
- $0.05
- Analyst Target Price
- $4
G Medical Innovations Holdings Ltd stock is currently trading at $0.07 per share. It touched a 52-week high of $11.8965 and a 52-week low of $11.8965. Analysts tracking the stock have a 12-month average target price of $4.
Its 50-day moving average was $0.22 and 200-day moving average was $1.45 The short ratio stood at 0.31 indicating a short percent outstanding of 0%.
Around 1528.4% of the company’s stock are held by insiders while 1691.8% are held by institutions.
Frequently Asked Questions About G Medical Innovations Holdings Ltd
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company’s products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.